-
1.
公开(公告)号:US20200261438A1
公开(公告)日:2020-08-20
申请号:US16867540
申请日:2020-05-05
Applicant: Versitech Limited
Inventor: Yi Tsun Richard KAO , Peng GAO , Xuechen LI , Ming LIU
IPC: A61K31/4545 , A61K31/40 , A61K31/4453 , A61K31/404 , A61K31/47 , A61K31/472 , A61K31/18 , A61K31/4458 , A61K31/4462 , A61K31/496 , A61P31/04
Abstract: Provided herein are compounds, derivatives thereof, composition comprising one or more of said compounds and derivatives, and methods for prevention and/or treatment of microbial infections and/or related diseases or conditions. The present compounds and/or derivatives thereof can be represented by Formula (II): The present methods include administering to a subject an effective amount of one or more compounds of Formula (II). In one embodiment, said microbial infections are bacterial infections. More specifically, said bacterial infections are staphylococcal infections.
-
公开(公告)号:US20200069642A1
公开(公告)日:2020-03-05
申请号:US16679313
申请日:2019-11-11
Applicant: Versitech Limited
Inventor: Yi Tsun Richard KAO , Peng GAO , Xuechen LI , Ming LIU
IPC: A61K31/40 , A61K31/496 , A61K31/47 , A61K31/454 , A61K31/4453 , A61K31/444 , A61K31/4406 , A61K31/4402 , A61K31/404 , A61K31/18 , A61K31/167 , A61K31/357 , A61P31/04 , C07D317/60 , C07D295/26
Abstract: Provided herein are compounds, derivatives thereof, composition comprising one or more of said compounds and derivatives, and methods for prevention and/or treatment of microbial infections and/or related diseases or conditions. The present compounds and/or derivatives thereof can be represented by Formula (I): The present methods include administering to a subject an effective amount of one or more compounds of Formula (I). In one embodiment, said microbial infections are bacterial infections. More specifically, said bacterial infections are staphylococcal infections.
-
3.
公开(公告)号:US20230278971A1
公开(公告)日:2023-09-07
申请号:US18316254
申请日:2023-05-12
Applicant: Versitech Limited
Inventor: Yi Tsun Richard KAO , Peng GAO , Xuechen LI , Ming LIU
IPC: C07D295/08 , A61K9/00 , C07D215/58 , C07D217/06 , A61P31/04
CPC classification number: C07D295/08 , A61K9/0095 , C07D215/58 , C07D217/06 , A61P31/04
Abstract: Provided herein are compounds, derivatives thereof, composition comprising one or more of said compounds and derivatives, and methods for prevention and/or treatment of microbial infections and/or related diseases or conditions. The present compounds and/or derivatives thereof can be represented by Formula (II):
The present methods include administering to a subject an effective amount of one or more compounds of Formula (II). In one embodiment, said microbial infections are bacterial infections. More specifically, said bacterial infections are staphylococcal infections.-
公开(公告)号:US20210309622A1
公开(公告)日:2021-10-07
申请号:US17352382
申请日:2021-06-21
Applicant: Versitech Limited
Inventor: Yi Tsun Richard KAO , Peng GAO , Xuechen LI , Ming LIU
IPC: C07D295/08 , A61K9/00 , C07D215/58 , C07D217/06 , A61P31/04
Abstract: Provided herein are compounds, derivatives thereof, composition comprising one or more of said compounds and derivatives, and methods for prevention and/or treatment of microbial infections and/or related diseases or conditions. The present compounds and/or derivatives thereof can be represented by Formula (II): The present methods include administering to a subject an effective amount of one or more compounds of Formula (II). In one embodiment, said microbial infections are bacterial infections. More specifically, said bacterial infections are staphylococcal infections.
-
公开(公告)号:US20230041593A1
公开(公告)日:2023-02-09
申请号:US17949184
申请日:2022-09-20
Applicant: Versitech Limited
Inventor: Yi Tsun Richard KAO , Peng GAO , Xuechen LI , Ming LIU
IPC: A61K31/40 , C07D295/26 , C07D317/60 , A61P31/04 , A61K31/357 , A61K31/167 , A61K31/18 , A61K31/404 , A61K31/4402 , A61K31/4406 , A61K31/444 , A61K31/4453 , A61K31/454 , A61K31/47 , A61K31/496
Abstract: Provided herein are compounds, derivatives thereof, composition comprising one or more of said compounds and derivatives prevention and/or treatment of microbial infections and/or related diseases or conditions. The present compounds and/or derivatives thereof can be represented by Formula (I): In one embodiment, said microbial infections are bacterial infections. More specifically, said bacterial infections are staphylococcal infections.
-
-
-
-